Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival


ARAZ Ö. , YILMAZEL UÇAR E. , MERAL M. , Yalcin A., ACEMOĞLU H., DOĞAN H. , et al.

CLINICAL RESPIRATORY JOURNAL, cilt.9, ss.297-304, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 9 Konu: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/crj.12143
  • Dergi Adı: CLINICAL RESPIRATORY JOURNAL
  • Sayfa Sayısı: ss.297-304

Özet

IntroductionLung cancer is the most common cause of cancer death in the world, and the most common type is non-small-cell lung cancer (NSCLC). At present, surgical resection, chemotherapy, and radiation therapy are the main treatments for patients with NSCLC, but unfortunately outcome remains unsatisfactory.